The theme “Everyday progress” seems appropriate for the imaging community in 2022. What a year it’s been. Supply ...
Molecular Imaging
Nuclear imaging, also called molecular imaging, includes positron emission computed tomography (PET) and single photon emission computed tomography (SPECT) imaging. This section includes radiopharmaceuticals and tracers, PET-CT, SPECT-CT, and PET-MRI. Molecular imaging includes the field of nuclear medicine, which uses very small amounts of radioactive materials, or radiopharmaceuticals, to diagnose and treat disease.
September 13, 2022 — For over 40 years the vision of Shared Medical Services (SMS) has been to provide innovative ...
September 12, 2022 — Royal Philips, a global leader in health technology, announced new milestones in the development of ...
Technological advancements in positron emission tomography/computed tomography (PET/CT) offer both clinicians and ...
September 8, 2022 — In prostate cancer patients experiencing recurrence following a radical prostatectomy, imaging with ...
September 7, 2022 — The American Society of Nuclear Cardiology (ASNC) and three partner societies have come together to ...
September 7, 2022 — Accuray Incorporated announced the company is joining forces with Genolier Innovation Hub, a fully ...
Efficiency and effectiveness are inseparable in clinical medicine. Digital PET addresses them both. The key is the ...
August 30, 2022 — RefleXion Medical, a therapeutic oncology company pioneering biology-guided radiotherapy* (BgRT), a ...
August 26, 2022 — NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and ...
August 19, 2022 — IBA (Ion Beam Applications S.A., EURONEXT), a world leader in particle accelerator technology and the ...
Introducing HYPERSCAN , Pencil Beam Scanning Delivery HYPERSCAN enables tumor volumes to be scanned in a matter of ...
August 16, 2022 — Mike Crosby of San Diego, California, has been elected to a two-year term as vice chair of the Patient ...
August 10, 2022 — The imaging community has lost a legend, recognized for having revolutionized the field of diagnostic ...
July 27, 2022 — Patients for Safer Nuclear Medicine, a coalition of 29 patient advocacy organizations representing ...
July 21, 2022 — According to ARRS’ American Journal of Roentgenology (AJR), understanding the likelihood of malignancy ...
July 20, 2022 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization ...
July 20, 2022 — -NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and ...
July 19, 2022 — Radialis Inc. today announced that it has received clearance to market the Radialis PET Imager, an organ ...
July 18, 2022 — Fresenius Kabi announced today it will introduce a portfolio of generic contrast media agents in the ...
July 11, 2022 — The "Molecular Imaging Market, by Application (Cancer, Heart Disease, Brain Disorder), by Technology ...
July 11, 2022 – The American Society of Nuclear Cardiology (ASNC) and the Society of Nuclear Medicine and Molecular ...
A patient’s chance of recovery can be directly impacted when a diagnosis is missed or delayed. To get the right ...